Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial-Reference-Cited by-同舟云学术

Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial

Published:2020-02 Issue:2 Volume:21 Page:294-305
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Migden Michael R,Khushalani Nikhil I,Chang Anne Lynn S,Lewis Karl D,Schmults Chrysalyne D,Hernandez-Aya Leonel,Meier Friedegund,Schadendorf Dirk,Guminski Alexander,Hauschild Axel,Wong Deborah J,Daniels Gregory A,Berking Carola,Jankovic Vladimir,Stankevich Elizabeth,Booth Jocelyn,Li Siyu,Weinreich David M,Yancopoulos George D,Lowy Israel,Fury Matthew G,Rischin Danny

Publisher

Elsevier BV

Subject

Oncology

Reference27 articles.

1. Gefitinib for patients with incurable cutaneous squamous cell carcinoma: a single-arm phase II clinical trial;William;J Am Acad Dermatol,2017

2. Phase II study of cetuximab as first-line single-drug therapy in patients with unresectable squamous cell carcinoma of the skin;Maubec;J Clin Oncol,2011

3. Phase II and biologic study of interferon alfa, retinoic acid, and cisplatin in advanced squamous skin cancer;Shin;J Clin Oncol,2002

4. Advanced cutaneous squamous cell carcinoma: a retrospective analysis of patient profiles and treatment patterns—results of a non-interventional study of the DeCOG;Hillen;Eur J Cancer,2018

5. Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer;Cavalieri;Eur J Cancer,2018

Cited by 339 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cutaneous Squamous Cell Carcinoma in Patients with Solid-Organ-Transplant-Associated Immunosuppression;Cancers;2024-09-04

2. Cutaneous Squamous Cell Carcinoma is a Different Diagnosis From Head and Neck Squamous Cell Carcinoma—Reply;JAMA Otolaryngology–Head & Neck Surgery;2024-09-01

3. Overexpression of CCL-20 and CXCL-8 genes enhances tumor escape and resistance to cemiplimab, a programmed cell death protein-1 (PD-1) inhibitor, in patients with locally advanced and metastatic cutaneous squamous cell carcinoma;OncoImmunology;2024-08-26

4. An “Older Old” Woman with Large Squamous Cell Carcinoma of the Nasal Pyramid: Excellent Response to Ultra-Hypofractionated Radiation Therapy;Radiation;2024-08-15

5. The hidden Australian skin cancer epidemic, high-risk cutaneous squamous cell carcinoma: a narrative review;Pathology;2024-08